Reaction
Extravascular Haemolysis reporting signals
As of the last recalculation, Extravascular Haemolysis appears in 414 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is RAVULIZUMAB (PRR 778.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ravulizumab | 139 | 778.0 | 786.1 |
| Eculizumab | 215 | 412.8 | 414.4 |
| Deferasirox | 16 | 31.5 | 31.5 |